Prognosis
Moderna Says New Vaccine for Omicron May Be Ready in Early 2022
- ‘Dangerous’ new variant could evade current shots, CMO says
- Company mobilized hundreds on Thanksgiving to start work
This article is for subscribers only.
Moderna Inc. shares gained after Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year.
“We should know about the ability of the current vaccine to provide protection in the next couple of weeks,” Burton said Sunday on the BBC’s “Andrew Marr Show.”